Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RGA | Common Stock | Options Exercise | $93.9K | +1.2K | +14.64% | $78.48 | 9.37K | Feb 7, 2024 | Direct | F1 |
transaction | RGA | Common Stock | Tax liability | -$95.2K | -563 | -6.01% | $169.01 | 8.8K | Feb 7, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RGA | Stock Appreciation Right (right to purchase) 2014 | Options Exercise | $0 | -2.23K | -100% | $0.00* | 0 | Feb 7, 2024 | Common Stock | 2.23K | $78.48 | Direct | F2 |
Id | Content |
---|---|
F1 | Represents (i) 1,037 shares sold to pay the exercise price the purchase of Common Stock, and (ii) 563 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 633 shares. |
F2 | SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |